
Moderna, racing to develop a vaccine for Covid-19, lost a key patent choice Thursday, one that might delay the businesss development or force it to hand over a cut of earnings.
The U.S. Patent and Tra … [+1420 chars]
Moderna, racing to develop a vaccine for Covid-19, lost a key patent choice Thursday, one that might delay the businesss development or force it to hand over a cut of earnings.
The U.S. Patent and Tra … [+1420 chars]